MEDEVA SEMPREX-D (Semprex-D 8 mg-60 mg)
Generic Name: acrivastine/pseudoephedrine
Pill with imprint MEDEVA SEMPREX-D is Green & White, Capsule-shape and has been identified as Semprex-D 8 mg-60 mg. It is supplied by Celltech Pharmaceuticals Inc..
Semprex-D is used in the treatment of allergic rhinitis; nasal congestion and belongs to the drug class upper respiratory combinations. There is no proven risk in humans during pregnancy. Semprex-D 8 mg-60 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MEDEVA SEMPREX-D
Semprex-D
- Generic Name
- acrivastine/pseudoephedrine
- Imprint
- MEDEVA SEMPREX-D
- Strength
- 8 mg-60 mg
- Color
- Green & White
- Size
- 16.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Upper respiratory combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Celltech Pharmaceuticals Inc.
- National Drug Code (NDC)
- 53014-0404
More about Semprex-D (acrivastine / pseudoephedrine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- 10 Reviews
- Drug class: upper respiratory combinations
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
